Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Rang in aandelen #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Aandeelprijs
$4.00
Laatst gesynchroniseerd: 2026-08-20
Marktkapitalisatie
$75.37M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
12.99%
Land
US
Handel RetinalGenix Technologies Inc. (RTGN)

Categorie

Aandelsplitsingen voor RetinalGenix Technologies Inc. (RTGN)
Het aandeel RetinalGenix Technologies Inc. (symbool: RTGN) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 22, 2026.
Eén aandeel RTGN dat vóór Aug 22, 2026 werd gekocht, staat nu gelijk aan 0 aandelen RTGN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE